Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.

CONTEXT The schizophrenia-susceptibility gene dysbindin (DTNBP1 on 6p22.3) encodes a neuronal protein that binds to beta-dystrobrevin and may be part of the dystrophin protein complex. Little is known about dysbindin expression in normal or schizophrenic brain. OBJECTIVES To determine whether brain regions implicated in schizophrenia express dysbindin and whether abnormal levels of dysbindin messenger RNA (mRNA) may be found in this disorder and to test whether sequence variations in the dysbindin gene in the promoter region, 5' and 3' untranslated regions, or introns would affect dysbindin mRNA levels. METHODS In patients with schizophrenia and controls, we compared dysbindin, synaptophysin, spinophilin, and cyclophilin mRNA levels in the dorsolateral prefrontal cortex and dysbindin mRNA levels in the midbrain by in situ hybridization. We genotyped brain DNA at 11 single nucleotide polymorphisms to determine whether genetic variation in the dysbindin gene affects cortical dysbindin mRNA levels. MAIN OUTCOME MEASURES Quantitative assessment of dysbindin mRNA levels across various brain regions and comparative studies of dysbindin mRNA levels in brains of patients with schizophrenia compared with normal controls. RESULTS Dysbindin mRNA was detected in the frontal cortex, temporal cortex, hippocampus, caudate, putamen, nucleus accumbens, amygdala, thalamus, and midbrain of the adult brain. Patients with schizophrenia had statistically significantly reduced dysbindin mRNA levels in multiple layers of the dorsolateral prefrontal cortex, whereas synaptophysin, spinophilin, and cyclophilin mRNA levels were unchanged. Dysbindin mRNA levels were quantitatively reduced in the midbrain of patients with schizophrenia, but not statistically significantly. Cortical dysbindin mRNA levels varied statistically significantly according to dysbindin genotype. CONCLUSIONS Dysbindin mRNA is expressed widely in the brain, and its expression is reduced in schizophrenia. Variation in dysbindin mRNA levels may be determined in part by variation in the promoter and the 5' and 3' untranslated regions. These data add to the evidence that dysbindin is an etiologic factor in schizophrenia risk.

[1]  P. Greengard,et al.  Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex , 2001, Biological Psychiatry.

[2]  I. Knuesel,et al.  GABAergic Terminals Are Required for Postsynaptic Clustering of Dystrophin But Not of GABAA Receptors and Gephyrin , 2002, The Journal of Neuroscience.

[3]  D. Weinberger,et al.  Prefrontal function in schizophrenia: confounds and controversies. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[4]  Richard Hawkes,et al.  Abnormal Dysbindin Expression in Cerebellar Mossy Fiber Synapses in the mdx Mouse Model of Duchenne Muscular Dystrophy , 2003, The Journal of Neuroscience.

[5]  C. R. Cloninger,et al.  The discovery of susceptibility genes for mental disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  小坂 浩隆,et al.  Differential amygdala response during facial recognition in patients with schizophrenia : An fMRI study , 2004 .

[7]  P. Greengard,et al.  The cDNA and derived amino acid sequences for rat and human synaptophysin. , 1987, Nucleic acids research.

[8]  L. Glantz,et al.  Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia , 2000, Biological Psychiatry.

[9]  Thomas G Schulze,et al.  Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study , 2000, Neuroscience Letters.

[10]  Masahiko Watanabe,et al.  Selective reduction of a PDZ protein, SAP‐97, in the prefrontal cortex of patients with chronic schizophrenia , 2002, Journal of neurochemistry.

[11]  B. Mowry,et al.  Molecular genetics of schizophrenia. , 2001, Clinical and experimental pharmacology & physiology.

[12]  J. Kleinman,et al.  The neuroanatomy and neurochemistry of schizophrenia. , 1998, The Psychiatric clinics of North America.

[13]  T. Südhof,et al.  Synaptophysin: structure of the human gene and assignment to the X chromosome in man and mouse. , 1990, American journal of human genetics.

[14]  S. Carbonetto,et al.  Dystroglycan contributes to the formation of multiple dystrophin‐like complexes in brain , 2001, Journal of neurochemistry.

[15]  M. Herkenham,et al.  Optimization of cRNA probein situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol , 1990, Cellular and Molecular Neurobiology.

[16]  M. Egan,et al.  Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. , 2000, Archives of general psychiatry.

[17]  L. Kunkel,et al.  beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. , 1997, The Journal of biological chemistry.

[18]  J. Kleinman,et al.  Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. , 1995, Archives of general psychiatry.

[19]  J John Mann,et al.  The GABAergic system in schizophrenia. , 2002, The international journal of neuropsychopharmacology.

[20]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[21]  J. Kleinman,et al.  Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia , 2003, Molecular Psychiatry.

[22]  A. Sampson,et al.  Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.

[23]  W. Honer,et al.  Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness , 1999, Neuroscience.

[24]  P. Goldman-Rakic,et al.  The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.

[25]  Naoki Oiso,et al.  Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) , 2003, Nature Genetics.

[26]  Alessandro Bertolino,et al.  Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study , 1998, Biological Psychiatry.

[27]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[28]  G Tedeschi,et al.  Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. , 1996, The American journal of psychiatry.

[29]  A. Guidotti,et al.  Dendritic Spine Hypoplasticity and Downregulation of Reelin and GABAergic Tone in Schizophrenia Vulnerability , 2001, Neurobiology of Disease.

[30]  P. McKenna,et al.  Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia , 2000, Neuroreport.

[31]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[32]  D. Blake,et al.  Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain* , 2001, The Journal of Biological Chemistry.

[33]  S. Hirsch,et al.  Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[34]  M. Blank,et al.  Molecular diversity of the dystrophin-like protein complex in the developing and adult avian retina , 2002, Neuroscience.

[35]  L. Jones.  Recent cytoarchitechtonic changes in the prefrontal cortex of schizophrenics. , 2001, Frontiers in bioscience : a journal and virtual library.

[36]  G. Feng,et al.  Family-based association study of DTNBP1 in 6p22.3 and schizophrenia , 2003, Molecular Psychiatry.

[37]  Paul J. Harrison,et al.  Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia , 2001, Hippocampus.

[38]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[39]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[40]  D. Blake,et al.  The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle? , 2000, Trends in Neurosciences.

[41]  J. Sanes,et al.  Maturation and Maintenance of the Neuromuscular Synapse Genetic Evidence for Roles of the Dystrophin–Glycoprotein Complex , 2000, Neuron.

[42]  David A Lewis,et al.  Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia , 2000, Brain Research Bulletin.

[43]  D. Weinberger,et al.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. , 1992, The American journal of psychiatry.

[44]  W. Bunney,et al.  Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia , 2000, Brain Research Reviews.

[45]  S. Grossberg.  The imbalanced brain: from normal behavior to schizophrenia , 2000, Biological Psychiatry.

[46]  P. Greengard,et al.  Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Kleinman,et al.  Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. , 2001, Cerebral cortex.

[48]  A. Monaco,et al.  Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. , 1992, Human molecular genetics.

[49]  J. Derry,et al.  Dystroglycan: brain localisation and chromosome mapping in the mouse. , 1994, Human molecular genetics.

[50]  B. Mowry,et al.  Proceedings of the Australian Neuroscience Society Symposium: Schizophrenia MOLECULAR GENETICS OF SCHIZOPHRENIA , 2001 .

[51]  M. Matsumoto,et al.  Full-length cDNA cloning and distribution of human dopamine D4 receptor. , 1995, Brain research. Molecular brain research.

[52]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[53]  J. Kleinman,et al.  Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development , 2003, Molecular Psychiatry.

[54]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[55]  P. Goldman-Rakic,et al.  Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three‐dimensional, stereologic counting method , 1998, The Journal of comparative neurology.

[56]  Daniel R. Weinberger,et al.  Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.

[57]  Simon C Watkins,et al.  Plasma membrane cytoskeleton of muscle: a fine structural analysis , 2000, Microscopy research and technique.

[58]  J. Sahel,et al.  Characterization of the intermolecular associations of the dystrophin-associated glycoprotein complex in retinal Müller glial cells. , 2000, Journal of cell science.

[59]  B. Dean,et al.  PSYCHIATRIC DIAGNOSIS AFTER DEATH: THE PROBLEMS OF ACCURATE DIAGNOSIS FROM CASE HISTORY REVIEW AND RELATIVE INTERVIEWS , 2019, Using CNS Autopsy Tissue in Psychiatric Research: A Practical Guide.

[60]  P. Goldman-Rakic,et al.  Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. , 2003, Archives of general psychiatry.

[61]  S. Ralston,et al.  Single nucleotide polymorphism detection: allelic discrimination using TaqMan. , 2002, Psychiatric genetics.

[62]  Nora I. Perrone-Bizzozero,et al.  Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia , 1998, Biological Psychiatry.

[63]  M. Owen,et al.  Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.

[64]  N. Varney,et al.  Psychopharmacology: The Fourth Generation of Progress. , 1996 .

[65]  Robin M. Chan,et al.  An fMRI study of facial emotion processing in patients with schizophrenia. , 2002, The American journal of psychiatry.

[66]  T. Hudson.  Wanted: regulatory SNPs , 2003, Nature Genetics.

[67]  S. Froehner,et al.  Absence of α-Syntrophin Leads to Structurally Aberrant Neuromuscular Synapses Deficient in Utrophin , 2000, The Journal of cell biology.

[68]  W Q Sturner,et al.  Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’ , 1999, Molecular Psychiatry.